N. Mazina

Efficacy of Complex Antioxidant Energy Correction of Different Durations in the Treatment of Cerebral Infarction (results of a multicenter randomized study)

V. Stupin, E. Silina, A. Kovalenko, 2017, Neuroscience and Behavioral Physiology.

[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].

M. Salnikov, A. Kovalenko, K. Golikov, 2015, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

The efficacy and safety of atezolizumab, nivolumab, and pembrolizumab as second-line therapy for non-small-cell lung cancer: preliminary data

P. Mazin, N. Mazina, 2018 .

[Effectiveness and safety of rufinamide at treatment of epilepsy with complications and drug-resistant epilepsy (according to meta-analysis data)].

P. Mazin, N. Mazina, I. V. Sheshunov, 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Clinical efficacy of the immunomodulatory agent cycloferon (tablets) in viral respiratory infections: Results of a systematic review and meta-analysis].

P. Mazin, A. Kovalenko, N. Mazina, 2017, Terapevticheskii arkhiv.

[Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disorders].

P. Mazin, N. Mazina, I. V. Sheshunov, 2017, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Meglumin acridonacetate to treat COVID-19: prospect of using

P. Mazin, A. Kovalenko, N. Mazina, 2020 .

Efficacy of Complex Antioxidant Energy Correction of Different Durations in the Treatment of Cerebral Infarction (results of a multicenter randomized study)

V. Stupin, E. Silina, A. Kovalenko, 2017, Neuroscience and Behavioral Physiology.